ReWalk Robotics Ltd. (NASDAQ:RWLK) and Wright Medical Group N.V. (NASDAQ:WMGI) compete with each other in the Medical Appliances & Equipment sector. We will analyze and contrast their analyst recommendations, profitability, risk, dividends, institutional ownership, earnings and valuation.

Earnings & Valuation

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ReWalk Robotics Ltd.	6.54M	74.66	21.68M	-0.62	0.00
Wright Medical Group N.V.	836.19M	4.66	169.30M	-1.18	0.00

Table 1 shows top-line revenue, earnings per share and valuation of the two companies.

Profitability

Table 2 represents ReWalk Robotics Ltd. (NASDAQ:RWLK) and Wright Medical Group N.V. (NASDAQ:WMGI)’s return on equity, net margins and return on assets.

	Net Margins	Return on Equity	Return on Assets
ReWalk Robotics Ltd.	-331.50%	0%	-140.8%
Wright Medical Group N.V.	-20.25%	-22.3%	-6.8%

Risk and Volatility

A 1.79 beta means ReWalk Robotics Ltd.’s volatility is 79.00% more than Standard and Poor’s 500’s volatility. Wright Medical Group N.V.’s 2.00% more volatile than Standard and Poor’s 500 which is a result of the 1.02 beta.

Liquidity

ReWalk Robotics Ltd.’s Current Ratio is 2.5 while its Quick Ratio is 2. On the competitive side is, Wright Medical Group N.V. which has a 1.3 Current Ratio and a 0.9 Quick Ratio. ReWalk Robotics Ltd. is better positioned to pay off short and long-term obligations compared to Wright Medical Group N.V.

Analyst Ratings

The table shown features the ratings and recommendations for ReWalk Robotics Ltd. and Wright Medical Group N.V.

	Sell Ratings	Hold Ratings	Buy Ratings	Rating Score
ReWalk Robotics Ltd.	0	1	0	2.00
Wright Medical Group N.V.	0	2	7	2.78

ReWalk Robotics Ltd.’s downside potential currently stands at -95.28% and an $0.25 average target price. On the other hand, Wright Medical Group N.V.’s potential upside is 14.78% and its average target price is $35.5. Based on the data shown earlier, Wright Medical Group N.V. is looking more favorable than ReWalk Robotics Ltd., analysts belief.

Insider and Institutional Ownership

The shares of both ReWalk Robotics Ltd. and Wright Medical Group N.V. are owned by institutional investors at 7.2% and 0% respectively. ReWalk Robotics Ltd.’s share held by insiders are 6.36%. Comparatively, 0.2% are Wright Medical Group N.V.’s share held by insiders.

Performance

In this table we provide the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

	Performance (W)	Performance (M)	Performance (Q)	Performance (HY)	Performance (Y)	Performance (YTD)
ReWalk Robotics Ltd.	-6.62%	-22.29%	9.65%	-75.85%	-79.51%	44.17%
Wright Medical Group N.V.	1.85%	6.9%	12.52%	11%	62.84%	17.19%

For the past year ReWalk Robotics Ltd. has stronger performance than Wright Medical Group N.V.

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe. ReWalk Robotics Ltd. markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was founded in 2001 and is headquartered in Yokneam Ilit, Israel.

Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells extremities and biologics products.in the United States, Europe, the Middle East, Africa, and internationally. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth. It also provides sports medicines and other products to mechanically repair tissue-to-tissue or tissue-to-bone injuries. The company primarily offers its products to orthopedic, trauma, and podiatric surgeons. Wright Medical Group N.V. markets and sells its products through direct sales representatives and independent sales agencies in the United States; and direct sales offices and distributors in approximately 50 countries. The company was founded in 1999 and is headquartered in Amsterdam, the Netherlands.